Here are five key points:
1. The market is expected to reach $34.57 billion by 2022, up from $18.26 billion in 2015.
2. Technological advancements and a large geriatric population will spur market growth.
3. Poor reimbursements will hinder market growth.
4. Zimmer Biomet leads the market.
5. Other key players include B. Braun/Aesculap, ConforMIS, Corin, DJO Hip, Exactech, Johnson & Johnson, Mathys AG, Medacta, MicroPort Orthopedics, Smith & Nephew, Stryker, Think Surgical, Waldemar LINK and Wright Medical.
More articles on devices:
St. Jude Medical shares increase 0.32%— 4 notes
Histogenics acquires sole development, marketing rights for NeoCart in Japan: 5 key notes
Study: Cartiva SCI an effective for toe osteoarthritis treatment — 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
